Literature DB >> 16144122

Helicobacter pylori eradication: equivalence trials and the optimal duration of therapy.

Nimish Vakil, Jason Connor.   

Abstract

Equivalence trials are gaining popularity and seek to compare the efficacy of two different types of treatment. The design of these trials requires careful consideration of clinical, statistical, and regulatory concerns. We discuss the importance and key factors relevant to equivalence trials.

Entities:  

Mesh：

Year:  2005        PMID： 16144122     DOI： 10.1111/j.1572-0241.2005.50615.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


  5 in total

1.  Is a 7-day Helicobater pylori treatment enough for eradication and inactivation of gastric inflammatory activity?

Authors:  Carlos Robles-Jara; Carlos Robles-Medranda; Manuel Moncayo; Byron Landivar; Johnny Parrales
Journal:  World J Gastroenterol       Date:  2008-05-14       Impact factor: 5.742

2.  Cost-effectiveness of six strategies for Helicobacter pylori diagnosis and management in uninvestigated dyspepsia assuming a high resource intensity practice pattern.

Authors:  Kyland P Holmes; John C Fang; Brian R Jackson
Journal:  BMC Health Serv Res       Date:  2010-12-21       Impact factor: 2.655

Review 3.  Evidence-based assessment of proton-pump inhibitors in Helicobacter pylori eradication: a systematic review.

Authors:  Vinayak Nagaraja; Guy D Eslick
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

Review 4.  Helicobacter pylori infection in older people.

Authors:  Alberto Pilotto; Marilisa Franceschi
Journal:  World J Gastroenterol       Date:  2014-06-07       Impact factor: 5.742

5.  An exotic cause of exudative enteropathy.

Authors:  Elena Tsourdi; Felix M Heidrich; Maria Winzer; Christoph Röllig; Christian Kirsch; Jörn Meinel; Gustavo B Baretton; Stefan R Bornstein; Lorenz C Hofbauer
Journal:  Am J Case Rep       Date:  2014-05-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.